Everolimus-eluting stent

DEVICE14 trials

Sponsors

Seung-Jung Park, North Texas Veterans Healthcare System, Takeshi Morimoto, Seoul National University Hospital, University Hospital, Basel, Switzerland

Conditions

Arterial Occlusive DiseasesArteriosclerosisCardiovascular DiseasesCoronary Artery DiseaseCoronary DiseaseCoronary OcclusionsCoronary ThrombosisHeart Diseases

Phase 4

AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO Study

CompletedNCT01012869

North Texas Veterans Healthcare SystemCoronary Occlusions

Start: 2009-11-30End: 2013-06-30Target: 100Updated: 2013-10-29

Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial

CompletedNCT01035450

Takeshi MorimotoCoronary Artery Disease

Start: 2010-02-28End: 2014-05-31Updated: 2015-12-10

Comparison of the Efficacy of Paclitaxel-releasing Balloon Catheter System Versus the Everolimus-Eluting Stent System for Treatment of In-Stent Restenosis Lesions - Harmonizing Optimal Strategy for Treatment of In-Stent Restenosis Lesions (The HOST-ISR Trial) -

Seoul National University HospitalIn-stent Restenosis Lesion

Target: 264Updated: 2023-04-20

Safety and Efficacy Study Comparing 3 New Types of Coronary Stents

CompletedNCT01166685

University Hospital, Basel, SwitzerlandCoronary Artery Disease, Coronary Thrombosis

Start: 2010-04-30End: 2014-05-31Updated: 2014-06-05

Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions

CompletedNCT01186120

Seung-Jung ParkCoronary Artery Disease

Start: 2010-08-31End: 2013-08-31Updated: 2013-11-06

NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial

CompletedNCT01303640

Takeshi MorimotoCoronary Artery Disease

Start: 2011-05-31End: 2015-10-31Updated: 2015-12-10

Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated With Bioresorbable and Metallic Stents at 1 Year

CompletedNCT02738658

Institut d'Investigació Biomèdica de BellvitgeStable Angina

Start: 2015-03-01End: 2018-07-02Updated: 2018-07-03

Unknown Phase

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

TerminatedNCT00997828

Seung-Jung ParkCoronary Artery Disease

Start: 2008-07-28End: 2019-04-05Updated: 2019-05-10

BES, EES, and ZES-R in Real World Practice

TerminatedNCT01397175

Yonsei UniversityCoronary Artery Disease

Start: 2013-01-16End: 2019-01-01Updated: 2019-07-09

Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion

CompletedNCT01887704

Capital Medical UniversityCoronary Artery Disease

Start: 2010-01-31End: 2013-05-31Updated: 2013-06-27

Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion

TerminatedNCT02739685

University of LuebeckCoronary Artery Disease

Start: 2016-09-30End: 2017-01-31Updated: 2019-09-26

Late Stent Strut Apposition and Coverage After Drug-Eluting Stent Implantation by OCT in Patients With AMI

Keimyung University Dongsan Medical CenterArterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases +5

Start: 2016-05-31End: 2018-12-31Target: 69Updated: 2018-01-25

Clinical evaluation of Alpine® vs. Xpedition® stent delivery system of the XIENCE® everolimus-eluting stent

Active, not recruitingNL-OMON45629

Universitair Medisch Centrum Groningenobstruction in the arteries that supply the heart with blood significant coronary stenosis

Start: 2017-10-05Target: 500Updated: 2024-02-28

Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers

Not yet recruitingNCT07566091

Jung-min AhnCoronary Artery Disease

Start: 2026-06-15End: 2028-06-15Target: 2034Updated: 2026-05-04

Related Papers

Late stent strut apposition and coverage after drug-eluting stent implantation by optical coherence tomography in patients with acute myocardial infarction.

2025-09-24

Long-term outcomes of intravascular ultrasound-guided percutaneous coronary intervention versus coronary artery bypass grafting for multivessel coronary artery disease.

2025-09-111 citations

Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study.

2023-10-014 citations

Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-Up Outcomes of Multicenter Randomized Controlled BEST Trial.

2022-09-1922 citations

Comparison of Different Types of Drug-Eluting Stents for De Novo Long Coronary Artery Lesions

JACC Asia2022-05-247 citations

External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI.

2022-04-017 citations

Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer Patients

Circulation Cardiovascular Interventions2020-03-019 citations

7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET Trial.

2019-04-0119 citations

Mortality impact of post-discharge myocardial infarction size after percutaneous coronary intervention: a patient-level pooled analysis from the 4 large-scale Japanese studies.

2018-03-052 citations

Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) Randomized Controlled Trials.

2017-05-0133 citations

Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery

Heart2016-09-2021 citations

Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.

2016-08-0140 citations

Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Circulation Cardiovascular Interventions2015-10-0162 citations

Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease

New England Journal of Medicine2015-03-16500 citations

Long-Term Efficacy and Safety of Biodegradable-Polymer Biolimus-Eluting Stents

Circulation2014-11-2092 citations

Comparison of Biolimus A9–Eluting (Nobori) and Everolimus-Eluting (Promus Element) Stents in Patients With De Novo Native Long Coronary Artery Lesions

Circulation Cardiovascular Interventions2014-05-1433 citations

Long-Term Clinical Outcomes After Everolimus- and Sirolimus-Eluting Coronary Stent Implantation

Circulation Cardiovascular Interventions2014-05-0741 citations

Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).

2012-07-23100 citations